Rifater Interactions
There are 941 drugs known to interact with Rifater (isoniazid/pyrazinamide/rifampin), along with 17 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 301 are major, 615 are moderate, and 25 are minor.
- View all 941 medications that may interact with Rifater
- View Rifater alcohol/food interactions (2)
- View Rifater disease interactions (17)
Most frequently checked interactions
View interaction reports for Rifater (isoniazid / pyrazinamide / rifampin) and the medicines listed below.
- Alphanate (antihemophilic factor/von willebrand factor)
- amitriptyline
- amlodipine
- B Complex 100 (multivitamin)
- Bactrim (sulfamethoxazole / trimethoprim)
- budesonide
- calcium carbonate
- carbamazepine
- ceftriaxone
- clarithromycin
- clonazepam
- colchicine
- Combivent (albuterol / ipratropium)
- diazepam
- enoxaparin
- Erelzi (etanercept)
- ethambutol
- famotidine
- fluconazole
- folic acid
- furosemide
- glucose
- ketorolac
- losartan
- metoclopramide
- omeprazole
- Paracetamol (acetaminophen)
- prednisone
- ranitidine
- sodium chloride
Rifater alcohol/food interactions
There are 2 alcohol/food interactions with Rifater (isoniazid / pyrazinamide / rifampin).
Rifater disease interactions
There are 17 disease interactions with Rifater (isoniazid / pyrazinamide / rifampin) which include:
- colitis
- hepatotoxicity
- liver disease
- peripheral neuropathy
- gout
- hepatotoxicity
- liver disease
- renal dysfunction
- hematopoietic disturbances
- hepatotoxicity
- liver disease
- porphyria
- hemodialysis
- renal dysfunction
- diabetes mellitus
- hemodialysis
- enzyme induction
Report options
More about Rifater (isoniazid / pyrazinamide / rifampin)
- Rifater consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antituberculosis combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
